- Home
- PLUG vs SLNO Comparison
PLUG vs SLNO Comparison
Compare PLUG & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUG | SLNO |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PLUG | SLNO |
|---|---|---|
| Price | $2.20 | $49.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $2.15 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 107.4M | 1.5M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $676,169,000.00 | $98,675,000.00 |
| Revenue This Year | $13.86 | N/A |
| Revenue Next Year | $21.99 | $155.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.53 | N/A |
| 52 Week Low | $0.69 | $41.50 |
| 52 Week High | $4.58 | $90.32 |
Technical Indicators
Market Signals| Indicator | PLUG | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 45.35 |
| Support Level | $2.16 | $48.60 |
| Resistance Level | $2.46 | $52.85 |
| Average True Range (ATR) | 0.17 | 2.57 |
| MACD | 0.04 | 0.46 |
| Stochastic Oscillator | 54.39 | 21.78 |
Price Performance
Historical ComparisonAbout PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.